Saxagliptin, marketed as Onglyza and Kombiglyze XR, is an anti-diabetic medication that has caused major complications in patients who take the drug. Saxagliptin side effects may include heart failure and certain types of cancers and is currently under review by the U.S. Food and Drug Administration (FDA).
If you or your loved one suffered serious saxagliptin side effects, speak to an attorney about your situation. It’s possible that you may qualify to file a claim or lawsuit against the manufacturer and receive a settlement for your losses. To discuss your case with a committed dangerous drug law firm, call Cordisco & Saile LLC at 215-642-2335.
Saxagliptin’s Intended Uses & Outcome
Saxagliptin, a medication that is in what’s called the dipeptidyl peptidase-4 (DPP-4) inhibitors class of medicines, is supposed to increase the quality of life in patients with type 2 diabetes. The medication “works by increasing the amount of insulin produced by the body after meals when blood sugar is high,” as MedlinePlus explains. It’s taken in tablet form, generally once a day.
As most patients are aware, diabetes can cause long-term health complications, such as heart disease, kidney problems, stroke and eye problems. Medicines such as saxagliptin are meant to lower the chances of developing complications. MedlinePlus further explains, “This therapy may also decrease your chances of having a heart attack, stroke, or other diabetes-related complications.”
Harmful Saxagliptin (Kombiglyze XR, Onglyza) Side Effects
Saxagliptin is meant to improve quality of life and help reduce the chances of heart disease in diabetics. But an article in the October 3, 2013 issue of The New England Journal of Medicine reported that taking saxagliptin increased the risk of hospitalization for heart failure by 27 percent compared to patients taking a placebo.
Furthermore, the FDA announced in 2013 that it was investigating saxagliptin and other drugs belonging in the class of drugs called incretin mimetics because of academic researchers’ claims that it increases patients’ risk of pancreatitis and pancreatic cancer.
The FDA’s Warning for Saxagliptin
The FDA is still investigating the effects of Saxagliptin and has yet to issue a formal warning. However, the agency does give the following recommendation: “Patients should not stop taking saxagliptin and should speak with their health care professionals about any questions or concerns.”
The FDA encourages patients to report adverse events or side effects of the drug to the FDA's MedWatch Safety Information and Adverse Event Reporting Program. You can report it online on the FDA’s site under MedWatch or call 1-800-332-1088 to request a report form.
Contacting a Saxagliptin Legal Advisor
If you or your loved one suffered injuries that you believe are associated with taking Saxagliptin, consult an injury or wrongful death attorney to discuss legal options. Collect all your medical records, doctors' notes and treatment history to share with your lawyer. If you haven’t done so already, start keeping a health journal to jot down the development of your condition. Include information such as treatments, pain levels and your reactions to treatment.
If your case meets all the requirements, your attorney can help pursue a claim against the manufacturer and fight for fair compensation to cover your damages.
Cordisco & Saile LLC Can Help
To speak with an attorney about your case, you are welcome to call Cordisco & Saile LLC. We are dedicated to helping patients and their families obtain the settlements they deserve after suffering unreasonable harm as a result of dangerous medications. Contact us today for a free consultation at 215-642-2335 or by filling out our online contact form.